| – |
The treatment of progressive myoclonus epilepsy (PME) remains a major therapeutic challenge in neurology. Generalized convulsive
seizures are often well controlled through classic antiepileptic drugs (AEDs) like valproate and clonazepam, whereas myoclonus,
the main symptom that is affecting patients most in their daily life, is usually refractory to standard AEDs.
|
| – |
Alternative therapy concepts have been and still are investigated. Among the new drugs, zonisamide and piracetam have shown
the most promising results as add-on treatments. Other therapeutic approaches, like the use of antioxidants,
|
| – |
5-hydroxytryptophan (5-HTP), and baclofen should also be taken into consideration for the treatment of intractable cases of
PME.
|
| – |
Nonpharmacologic treatment options such as diet and physical therapy should always be considered, because they may save costs
and side effects.
|
| – |
In some instances, the occasional use of alcohol has shown beneficial effects.
|